A novel application utilising data from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) has been developed by a Biomedical Informatics team at the Cincinnati Children’s Hospital Medical Center.

AERSMine has been developed to allow users to analyse and identify differential clinical outcomes to various drug regimes, within different patient subgroups and accounting for other treatment-related factors.

Read more about the tool:

Sarangdhar, M. et al. Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data. Nat. Biotechnol. 34, 697-700 (2016)

And have a go at the tool yourself by clicking here.

 

Reply

Please Sign in (or Register) to view further.